Search
Aesthetic Medical Technology has announced that its subsidiary, REGEN Biotech, Inc., has been served with an arbitration application filed with the Shenzhen Court of International Arbitration. This application, initiated by Datou Medical Devices (Shanghai) Co., Ltd., involves a case with a potential claim of up to RMB 1.6 billion. The request by Datou Medical Devices seeks confirmation of exclusive agency rights and compensation for incurred losses.
Currently, the arbitration case has not yet reached the trial phase, thus the potential impact on Aesthetic Medical Technology's current and future profits remains uncertain. In response, both Aesthetic Medical Technology and REGEN Biotech have stated their commitment to actively engage in the legal proceedings and to uphold their obligations in terms of information disclosure.
-
C114 Communication Network -
Communication Home
